Literature DB >> 7511143

Residues within a conserved amino acid motif of domains 1 and 4 of VCAM-1 are required for binding to VLA-4.

R H Vonderheide1, T F Tedder, T A Springer, D E Staunton.   

Abstract

Vascular cell adhesion molecule 1 (VCAM-1), a member of the Ig superfamily originally identified on activated endothelium, binds to the integrin very late antigen-4 (VLA-4), also known as alpha 4 beta 1 or CD49d/CD29, to support cell-cell adhesion. Studies based on cell adhesion to two alternatively spliced forms of VCAM-1 or to chimeric molecules generated from them and intercellular adhesion molecule-1 (ICAM-1) have demonstrated two VLA-4 binding sites on the predominate form of VCAM-1. Here, we studied VLA-4-dependent adhesion of the lymphoid tumor cell line Ramos to cells expressing wild type and mutant forms of VCAM-1. Results based on domain deletion mutants demonstrated the existence and independence of two VLA-4-binding sites located in the first and fourth domains of VCAM-1. Results based on amino acid substitution mutants demonstrated that residues within a linear sequence of six amino acids found in both domain 1 and 4 were required for VLA-4 binding to either domain. Five of these amino acids represent a conserved motif also found in ICAM domains. We propose that integrin binding to these Ig-like domains depends on residues within this conserved motif. Specificity of integrin binding to Ig-like domains may be regulated by a set of nonconserved residues distinct from the conserved motif.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7511143      PMCID: PMC2120002          DOI: 10.1083/jcb.125.1.215

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  66 in total

1.  Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

Authors:  T A Yednock; C Cannon; L C Fritz; F Sanchez-Madrid; L Steinman; N Karin
Journal:  Nature       Date:  1992-03-05       Impact factor: 49.962

2.  Isolation, characterization, and expression of mouse ICAM-2 complementary and genomic DNA.

Authors:  H Xu; I L Tong; A R De Fougerolles; T A Springer
Journal:  J Immunol       Date:  1992-10-15       Impact factor: 5.422

3.  Induction of VCAM-1 and ICAM-1 on human neural cells and mechanisms of mononuclear leukocyte adherence.

Authors:  H H Birdsall; C Lane; M N Ramser; D C Anderson
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

4.  Increased binding of synovial T lymphocytes from rheumatoid arthritis to endothelial-leukocyte adhesion molecule-1 (ELAM-1) and vascular cell adhesion molecule-1 (VCAM-1).

Authors:  A A Postigo; R Garcia-Vicuña; F Diaz-Gonzalez; A G Arroyo; M O De Landázuri; G Chi-Rosso; R R Lobb; A Laffon; F Sánchez-Madrid
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

5.  Cloning of murine and rat vascular cell adhesion molecule-1.

Authors:  C Hession; P Moy; R Tizard; P Chisholm; C Williams; M Wysk; L Burkly; K Miyake; P Kincade; R Lobb
Journal:  Biochem Biophys Res Commun       Date:  1992-02-28       Impact factor: 3.575

6.  Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes.

Authors:  J Fawcett; C L Holness; L A Needham; H Turley; K C Gatter; D Y Mason; D L Simmons
Journal:  Nature       Date:  1992-12-03       Impact factor: 49.962

7.  Cloning and characterization of a new intercellular adhesion molecule ICAM-R.

Authors:  R Vazeux; P A Hoffman; J K Tomita; E S Dickinson; R L Jasman; T St John; W M Gallatin
Journal:  Nature       Date:  1992-12-03       Impact factor: 49.962

8.  Soluble intercellular adhesion molecule 1-immunoglobulin G1 immunoadhesin mediates phagocytosis of malaria-infected erythrocytes.

Authors:  D E Staunton; C F Ockenhouse; T A Springer
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

9.  Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells.

Authors:  N Jonjić; G Peri; S Bernasconi; F L Sciacca; F Colotta; P Pelicci; L Lanfrancone; A Mantovani
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

10.  Tumor necrosis factor alpha induces adhesion molecule expression on human fetal astrocytes.

Authors:  A A Hurwitz; W D Lyman; M P Guida; T M Calderon; J W Berman
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  37 in total

1.  An atomic resolution view of ICAM recognition in a complex between the binding domains of ICAM-3 and integrin alphaLbeta2.

Authors:  Gang Song; Yuting Yang; Jin-Huan Liu; Jose M Casasnovas; Motomu Shimaoka; Timothy A Springer; Jia-Huai Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

2.  Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs.

Authors:  Qing Chen; Xiang H-F Zhang; Joan Massagué
Journal:  Cancer Cell       Date:  2011-10-18       Impact factor: 31.743

3.  Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions.

Authors:  J Pappo; D Torrey; L Castriotta; A Savinainen; Z Kabok; A Ibraghimov
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 4.  The pathophysiologic role of alpha 4 integrins in vivo.

Authors:  R R Lobb; M E Hemler
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

Review 5.  The intercellular adhesion molecule (ICAM) family of proteins. New members and novel functions.

Authors:  J S Hayflick; P Kilgannon; W M Gallatin
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

6.  Molecular pathways: VCAM-1 as a potential therapeutic target in metastasis.

Authors:  Qing Chen; Joan Massagué
Journal:  Clin Cancer Res       Date:  2012-08-09       Impact factor: 12.531

Review 7.  Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants.

Authors:  Joan M Cook-Mills; Michelle E Marchese; Hiam Abdala-Valencia
Journal:  Antioxid Redox Signal       Date:  2011-05-11       Impact factor: 8.401

8.  How natalizumab binds and antagonizes α4 integrins.

Authors:  Yamei Yu; Thomas Schürpf; Timothy A Springer
Journal:  J Biol Chem       Date:  2013-09-18       Impact factor: 5.157

9.  Differential regulation of beta 1 and beta 2 integrin avidity by chemoattractants in eosinophils.

Authors:  C Weber; J Kitayama; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

10.  A functional integrin ligand on the surface of platelets: intercellular adhesion molecule-2.

Authors:  T G Diacovo; A R deFougerolles; D F Bainton; T A Springer
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.